Compare Vaxcyte Inc. Common Stock (PCVX) vs TD SYNNEX Corporation Common Stock (SNX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vaxcyte Inc. Common Stock vs TD SYNNEX Corporation Common Stock — how do they compare? Vaxcyte Inc. Common Stock trades at $67.37 (market cap $10.51B), while TD SYNNEX Corporation Common Stock trades at $262 (market cap $22.02B). The key difference: TD SYNNEX Corporation Common Stock is far larger — about 2.1× Vaxcyte Inc. Common Stock's market cap, and TD SYNNEX Corporation Common Stock pays a 0.7% dividend while Vaxcyte Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Vaxcyte Inc. Common Stock for 0 Days and TD SYNNEX Corporation Common Stock for 0 Days on average.
| PCVX | SNX | |
|---|---|---|
Market Cap | $10.51B | $22.02B |
Volume | 2,644,694 | 614,208 |
Sector | Health | Technology |
52-Week High | $73.82 | $290.14 |
52-Week Low | $40.32 | $142.42 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $9.14B | $26.79B |
Dividend Yield | — | 0.7% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Vaxcyte Inc. Common Stock
Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.
Read more on PCVX →About TD SYNNEX Corporation Common Stock
TD SYNNEX Corporation is a global IT distributor and solutions aggregator that distributes endpoint devices and data-center technologies from technology vendors to resellers and customers worldwide.
Read more on SNX →
